SCHEMBL31636439

SCHEMBL31636439

COC(=O)c1ccc(Cl)c(Oc2ccccc2)c1CBr

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.43
▸ NPBWR1 P48145 1/20 0.42
▸ LMNA P02545 4/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ MAPT P10636 3/20 0.40
▸ POLB P06746 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ TSHR P16473 1/20 0.39
▸ MAPK10 P53779 1/20 0.39
▸ KDM4E B2RXH2 4/20 0.38
▸ TSPO P30536 2/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ GAA P10253 2/20 0.37
▸ RHEB Q15382 1/20 0.37
▸ NR4A2 P43354 1/20 0.37
▸ GLA P06280 1/20 0.37
▸ HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4804791 0.81 TDP1 (0.47) TDP1NPBWR1LMNAMEN1KMT2A
SCHEMBL31636717 0.77 ABL1 (0.42) LMNAMEN1KMT2ASMN1; SMN2MAPT
SCHEMBL30993736 0.76 ABL1 (0.41) LMNAMEN1KMT2ASMN1; SMN2MAPT
SCHEMBL2251382 0.75 ABL1 (0.35) TDP1LMNAMEN1KMT2ASMN1; SMN2
SCHEMBL8747840 0.75 ABL1 (0.41) LMNAMEN1KMT2ASMN1; SMN2MAPT
SCHEMBL1035578 0.74 NR4A2 (0.48) LMNAKMT2AMAPTPOLBALDH1A1
SCHEMBL3436908 0.74 ABL1 (0.42) LMNAMEN1KMT2ASMN1; SMN2MAPT
SCHEMBL24745526 0.73 ATR (0.39) LMNAMEN1KMT2AALDH1A1TSHR
SCHEMBL27666406 0.72 KDM4E (0.51) TDP1NPBWR1LMNAMEN1KMT2A
SCHEMBL18756750 0.72 XDH (0.51) TDP1LMNAMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025137158-A1 DERIVATIVES OF ([1,2,4]TRIAZOLO[5,1-A]ISOQUINOLINE-5-CARBONYL)GLYCINATE AS PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF USE AKEBIA THERAPEUTICS, INC. (US) 2025-06-26 — — WO disclosed
Send feedback